Bioventus launches $210 million term loan B at Libor plus 625 bps

By Sara Rosenberg

New York, Oct. 19 – Bioventus LLC launched on Wednesday a $210 million six-year term loan B with price talk of Libor plus 625 basis points with a 1% Libor floor and an original issue discount of 98, according to a market source.

The term loan has 101 soft call protection for one year, the source said.

J.P. Morgan Securities LLC is the lead bank on the deal.

Proceeds will be used to refinance existing debt and for general corporate purposes.

Bioventus is a Durham, N.C.-based orthopedic healing company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.